Literature DB >> 1384325

Mutations of the KIT (mast/stem cell growth factor receptor) proto-oncogene account for a continuous range of phenotypes in human piebaldism.

R A Spritz1, S A Holmes, R Ramesar, J Greenberg, D Curtis, P Beighton.   

Abstract

Piebaldism is a rare autosomal dominant disorder of pigmentation, characterized by congenital patches of white skin and hair from which melanocytes are absent. We have previously shown that piebaldism can result from missense and frameshift mutations of the KIT proto-oncogene, which encodes the cellular receptor tyrosine kinase for the mast/stem cell growth factor. Here, we report two novel KIT mutations associated with human piebaldism. A proximal frameshift is associated with a mild piebald phenotype, and a splice-junction mutation is associated with a highly variable piebald phenotype. We discuss the apparent relationship between the predicted impact of specific KIT mutations on total KIT-dependent signal transduction and the severity of the resultant piebald phenotypes.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1384325      PMCID: PMC1682829     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  29 in total

1.  Expression of a dominant negative mutant of the FGF receptor disrupts mesoderm formation in Xenopus embryos.

Authors:  E Amaya; T J Musci; M W Kirschner
Journal:  Cell       Date:  1991-07-26       Impact factor: 41.582

2.  Mouse platelet-derived growth factor receptor alpha gene is deleted in W19H and patch mutations on chromosome 5.

Authors:  E A Smith; M F Seldin; L Martinez; M L Watson; G G Choudhury; P A Lalley; J Pierce; S Aaronson; J Barker; S L Naylor
Journal:  Proc Natl Acad Sci U S A       Date:  1991-06-01       Impact factor: 11.205

3.  Inhibition of PDGF beta receptor signal transduction by coexpression of a truncated receptor.

Authors:  H Ueno; H Colbert; J A Escobedo; L T Williams
Journal:  Science       Date:  1991-05-10       Impact factor: 47.728

Review 4.  Signal transduction by receptors with tyrosine kinase activity.

Authors:  A Ullrich; J Schlessinger
Journal:  Cell       Date:  1990-04-20       Impact factor: 41.582

Review 5.  Growth factor receptor tyrosine kinases.

Authors:  Y Yarden; A Ullrich
Journal:  Annu Rev Biochem       Date:  1988       Impact factor: 23.643

6.  Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase.

Authors:  R K Saiki; D H Gelfand; S Stoffel; S J Scharf; R Higuchi; G T Horn; K B Mullis; H A Erlich
Journal:  Science       Date:  1988-01-29       Impact factor: 47.728

7.  Dominant piebald trait in a retarded child with a reciprocal translocation and small intercalary deletion.

Authors:  S J Funderburk; B F Crandall
Journal:  Am J Hum Genet       Date:  1974-11       Impact factor: 11.025

8.  Mutation of the KIT (mast/stem cell growth factor receptor) protooncogene in human piebaldism.

Authors:  L B Giebel; R A Spritz
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-01       Impact factor: 11.205

9.  Platelet-derived growth factor receptor alpha-subunit gene (Pdgfra) is deleted in the mouse patch (Ph) mutation.

Authors:  D A Stephenson; M Mercola; E Anderson; C Y Wang; C D Stiles; D F Bowen-Pope; V M Chapman
Journal:  Proc Natl Acad Sci U S A       Date:  1991-01-01       Impact factor: 11.205

10.  Interstitial deletion of the proximal long arm of chromosome 4 associated with father-child incompatibility within the Gc-system: probable reduced gene dosage effect and partial piebald trait.

Authors:  Y Yamamoto; H Nishimoto; S Ikemoto
Journal:  Am J Med Genet       Date:  1989-04
View more
  14 in total

1.  Polymerase chain reaction detection of a novel human KIT (mast/stem cell growth factor receptor) gene polymorphism by single-strand conformation polymorphism analysis or by SmaI or BstNI cleavage.

Authors:  R A Spritz; S A Holmes
Journal:  Hum Genet       Date:  1993-09       Impact factor: 4.132

2.  "Mistakes happen": somatic mutation and disease.

Authors:  F Qian; G G Germino
Journal:  Am J Hum Genet       Date:  1997-11       Impact factor: 11.025

3.  Pigmentation, pleiotropy, and genetic pathways in humans and mice.

Authors:  G S Barsh
Journal:  Am J Hum Genet       Date:  1995-10       Impact factor: 11.025

Review 4.  The molecular basis of genetic dominance.

Authors:  A O Wilkie
Journal:  J Med Genet       Date:  1994-02       Impact factor: 6.318

5.  Assessment of hepatitis C virus sequence complexity by electrophoretic mobilities of both single-and double-stranded DNAs.

Authors:  Y M Wang; S C Ray; O Laeyendecker; J R Ticehurst; D L Thomas
Journal:  J Clin Microbiol       Date:  1998-10       Impact factor: 5.948

6.  The p53 tumor suppressor causes congenital malformations in Rpl24-deficient mice and promotes their survival.

Authors:  Martina Barkić; Sladana Crnomarković; Kristina Grabusić; Ivana Bogetić; Linda Panić; Sanda Tamarut; Maja Cokarić; Ines Jerić; Sandra Vidak; Sinisa Volarević
Journal:  Mol Cell Biol       Date:  2009-03-09       Impact factor: 4.272

7.  The hereditary renal cell carcinoma 3;8 translocation fuses FHIT to a patched-related gene, TRC8.

Authors:  R M Gemmill; J D West; F Boldog; N Tanaka; L J Robinson; D I Smith; F Li; H A Drabkin
Journal:  Proc Natl Acad Sci U S A       Date:  1998-08-04       Impact factor: 11.205

8.  Mutations of the tyrosinase gene in patients with oculocutaneous albinism from various ethnic groups in Israel.

Authors:  R Gershoni-Baruch; A Rosenmann; S Droetto; S Holmes; R K Tripathi; R A Spritz
Journal:  Am J Hum Genet       Date:  1994-04       Impact factor: 11.025

9.  Frequent intragenic deletion of the P gene in Tanzanian patients with type II oculocutaneous albinism (OCA2).

Authors:  R A Spritz; K Fukai; S A Holmes; J Luande
Journal:  Am J Hum Genet       Date:  1995-06       Impact factor: 11.025

10.  Oculocutaneous albinism type 4 is one of the most common types of albinism in Japan.

Authors:  Katsuhiko Inagaki; Tamio Suzuki; Hiroshi Shimizu; Norihisa Ishii; Yoshinori Umezawa; Joji Tada; Noriaki Kikuchi; Minoru Takata; Kenji Takamori; Mari Kishibe; Michi Tanaka; Yoshinori Miyamura; Shiro Ito; Yasushi Tomita
Journal:  Am J Hum Genet       Date:  2004-02-11       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.